SpliSense Ltd., is a growing and exciting biotechnology company, developing novel therapies for genetic diseases by inhalation. The company is currently focusing on splicing mutations in the CFTR gene for treating Cystic Fibrosis (CF) patients.
| Website | http://www.splisense.com |
| Employees | 16 (10 on RocketReach) |
| Founded | 2017 |
| Industry | Biotechnology Research |
| Keywords | Cystic Fibrosis Treatment, Biotechnology, Genetic Diseases, Gene Therapy, Novel Therapies, Pulmonary Drug Delivery, Drug Development, Rare Diseases, Molecular Medicine, Respiratory Diseases, Biotechnology Research, Biopharmaceutical, Pharmaceutical Research, Clinical Trials, Genetic Engineering, Precision Medicine, Therapeutics |
| Competitors | Meltwater, Sprout Social, Inc., Hootsuite, Talkwalker, NetBase Solutions, Inc., Mention, Crimson Hexagon, DataSift, Sysomos Expion, BuzzSumo +44 more (view full list) |
Looking for a particular Splisense employee's phone or email?
Gili Hart is the CEO of Splisense.
10 people are employed at Splisense.